Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TECH | Common Stock | Award | $0 | +194 | +40.42% | $0.00 | 674 | Oct 28, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TECH | Stock Option (right to buy) | Award | $0 | +633 | $0.00 | 633 | Oct 28, 2021 | Common Stock | 633 | $515.24 | Direct | F1 | |
holding | TECH | Stock Option (right to buy) | 361 | Oct 28, 2021 | Common Stock | 361 | $278.87 | Direct | ||||||
holding | TECH | Stock Option (right to buy) | 1.51K | Oct 28, 2021 | Common Stock | 1.51K | $255.69 | Direct |
Id | Content |
---|---|
F1 | The option vests on the earlier of the one year anniversary of the grant date (10/28/2021) or the date of Bio-Techne's 2022 annual meeting of shareholders. |